These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1645569

  • 1. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines.
    Doyle LA, Mabry M, Stahel RA, Waibel R, Goldstein LH.
    Br J Cancer Suppl; 1991 Jun; 14():39-42. PubMed ID: 1645569
    [Abstract] [Full Text] [Related]

  • 2. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G, Adamkiewicz J, Wimmel A, Schuermann M.
    Oncogene; 1998 Jun 11; 16(23):3057-68. PubMed ID: 9662339
    [Abstract] [Full Text] [Related]

  • 3. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
    Takahashi T, Obata Y, Sekido Y, Hida T, Ueda R, Watanabe H, Ariyoshi Y, Sugiura T, Takahashi T.
    Cancer Res; 1989 May 15; 49(10):2683-8. PubMed ID: 2540905
    [Abstract] [Full Text] [Related]

  • 4. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
    van Waardenburg RC, Meijer C, Pinto-Sietsma SJ, de Vries EG, Timens W, Mulder NM.
    Anticancer Res; 1998 May 15; 18(1A):91-5. PubMed ID: 9568061
    [Abstract] [Full Text] [Related]

  • 5. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G, Bading H, Heimann B, Kiefer P, Havemann K, Moelling K.
    Oncogene; 1989 Jan 15; 4(1):45-50. PubMed ID: 2536917
    [Abstract] [Full Text] [Related]

  • 6. The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.
    Barr LF, Campbell SE, Tamez P, Casero RA.
    Clin Cancer Res; 1998 Jun 15; 4(6):1557-61. PubMed ID: 9626477
    [Abstract] [Full Text] [Related]

  • 7. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF, Campbell SE, Bochner BS, Dang CV.
    Cancer Res; 1998 Dec 01; 58(23):5537-45. PubMed ID: 9850091
    [Abstract] [Full Text] [Related]

  • 8. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid.
    Doyle LA, Giangiulo D, Hussain A, Park HJ, Yen RW, Borges M.
    Cancer Res; 1989 Dec 01; 49(23):6745-51. PubMed ID: 2555051
    [Abstract] [Full Text] [Related]

  • 9. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
    Shivapurkar N, Reddy J, Matta H, Sathyanarayana UG, Huang CX, Toyooka S, Minna JD, Chaudhary PM, Gazdar AF.
    Oncogene; 2002 Dec 05; 21(55):8510-4. PubMed ID: 12466971
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
    Waibel R, Mannhart M, O'Hara CJ, Brocklehurst C, Zangemeister-Wittke U, Schenker T, Lehmann HP, Weber E, Stahel RA.
    Cancer Res; 1993 Jun 15; 53(12):2840-5. PubMed ID: 7684948
    [Abstract] [Full Text] [Related]

  • 11. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.
    Watanabe H, Takahashi T, Ueda R, Utsumi KR, Sato T, Ariyoshi Y, Ota K, Obata Y, Takahashi T.
    Cancer Res; 1988 May 01; 48(9):2544-9. PubMed ID: 2833350
    [Abstract] [Full Text] [Related]

  • 12. Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells.
    Doyle LA, Cuttitta F, Mulshine JL, Bunn PA, Minna JD.
    Cancer Res; 1987 Oct 01; 47(19):5009-13. PubMed ID: 3040237
    [Abstract] [Full Text] [Related]

  • 13. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer.
    Kalemkerian GP, Jasti RK, Celano P, Nelkin BD, Mabry M.
    Cell Growth Differ; 1994 Jan 01; 5(1):55-60. PubMed ID: 8123593
    [Abstract] [Full Text] [Related]

  • 14. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35.
    Takahashi T, Ueda R, Song X, Nishida K, Shinzato M, Namikawa R, Ariyoshi Y, Ota K, Kato K, Nagatsu T.
    Cancer Res; 1986 Sep 01; 46(9):4770-5. PubMed ID: 3015397
    [Abstract] [Full Text] [Related]

  • 15. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
    Rosen ST, Mulshine JL, Cuttitta F, Fedorko J, Carney DN, Gazdar AF, Minna JD.
    Cancer Res; 1984 May 01; 44(5):2052-61. PubMed ID: 6713399
    [Abstract] [Full Text] [Related]

  • 16. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW, Lee J, Stone MJ.
    Cancer Res; 1984 Nov 01; 44(11):4987-92. PubMed ID: 6207911
    [Abstract] [Full Text] [Related]

  • 17. Molecular genetics of small cell lung carcinoma.
    Wistuba II, Gazdar AF, Minna JD.
    Semin Oncol; 2001 Apr 01; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
    Hay FG, Duncan LW, Langdon SP, Leonard RC.
    Br J Cancer Suppl; 1991 Jun 01; 14():33-5. PubMed ID: 1645568
    [Abstract] [Full Text] [Related]

  • 19. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ.
    Ann Thorac Surg; 1995 Dec 01; 60(6):1583-91. PubMed ID: 8787447
    [Abstract] [Full Text] [Related]

  • 20. Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis.
    Myklebust AT, Beiske K, Pharo A, Davies CD, Aamdal S, Fodstad O.
    Br J Cancer Suppl; 1991 Jun 01; 14():49-53. PubMed ID: 1645572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.